Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

IOHEXOL INJECTION

Active
SPE2DP-26-T-5366Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

PO BOX 7003, PASCAGOULA, MS, 39567-7003, USA

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-5366.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Office AddressUSA
Contacts

Full Description

Show more
IOHEXOL INJECTION
IOHEXOL INJECTION, USP; 300MG, 10'S 300MG/ML 150ML POLYMER BOTTLE 10S;
FILL IN 150 ML IN + PLUSPAK POLYMER BOTTLE RADIOLOGICAL/CONTRAST MEDIA
UNIT OF ISSUE (1) "BOX"
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
PROTECT FROM STRONG DAYLIGHT AND DIRECT EXPOSURE TO SUNLIGHT. DO NOT
FREEZE. STORE AT CONTROLLED ROOM TEMPERATURE, 20 -25 C (68 77 F);
EXCURSIONS PERMITTED TO 15 -30 C (59 -86 F) SEE USP CONTROLLED ROOM
TEMPERATURE
Hazard Communication Standard Notice:
Effective June 1, 2015, Federal Standard No. 313-E, Material Safety Data, Transportation Data and Disposal Data for Hazardous Materials Furnished to Government Activities, establishes the requirement for preparation and submission of Safety Data Sheets (SDS) in lieu of Material Safety Data Sheets (MSDS) by suppliers who provide hazardous materials to government activities.
The Occupational Safety and Health Administration (OSHA) has modified its Hazard Communication Standard (HCS) to conform to the United Nations Globally Harmonized System of Classification and Labeling of Chemicals. As a result of this change, GSA revised Federal Standard No. 313-E requiring Safety Data Sheets for classifying chemicals and communicating the applicable information on labels.
In accordance with the revised standard after June 1, 2015:
1. Suppliers will be required to submit, to the contracting officer for review and approval prior to award, safety data sheets consistent with the requirements found at 29 C.F.R. 1910.1200 for hazardous materials delivered to the Government.
2. Suppliers will also be required to submit, to the contracting officer for review and approval prior to award, Hazardous Communication Standard (HCS) labels in accordance with 29 C.F.R. 1910.1200 requirements or current Consumer Product Safety Act (CPSA), Federal Hazardous Substance Act (FHSA) labels when subject to labeling requirements under those statutes. This product labeling is required for hazardous materials delivered to the Government.
3. Finally, suppliers must train their employees on the new safety data sheets, hazardous communication labels, and requirements of 29 C.F.R. 1910.1200.
For more information on SDS, refer to OSHAs website, available at:
SPE2DP-26-T-5366
SECTION B
https://www.osha.gov/law-regs.html
For information on 29 C.F.R. 1910.1200, refer to the below link:
https://www.osha.gov/dsg/hazcom/index.html
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
GE HEALTHCARE INC 0AY96 P/N NDC00407-1413-65
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018563519 0001 BX 2.000
NSN/MATERIAL:6505016659178
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
SPE2DP-26-T-5366
SECTION B
PR: 7018563519 PRLI: 0001 CONT’D
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N27502
PCU BOUGAINVILLE (LHA 8)
PO BOX 7003
PASCAGOULA MS 39567-7003
US
RDD 999/NMCS SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
N27502
PCU BOUGAINVILLE (LHA 8)
COSAL WAREHOUSE #2
13486 FASTWAY LANE
GULFPORT MS 39503
US
M/F: (TCN) N275026269ZH40
RDD: 999
PROJ: ZD8 TP 1
SUPP ADD: N62645 SIG: B
FOR GOVERNMENT USE ONLY: (IPD) 03
DIC: A4A DIST: M9L ADV: 2A FC: Y6
Need Ship Date:00/00/0000 Original Required Delivery Date:10/01/2026
SPE2DP-26-T-5366 NSN/Part Number: 6505-01-665-9178 Quantity: 2 BX Purchase Request: 7018563519QTY: 2 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
DIBBS
BENZOIN TINCTURE, COMPO
Solicitation # SPE2DP-26-T-5290
This solicitation, issued by DLA Troop Support Medical Supply Chain Pharm FSA under number SPE2DP-26-T-5290, is a request for quotations for Compound Benzoin Tincture, USP. The product is an over-the-counter topical solution for external use, containing 1000 mg of benzoin resin per 1 ml and 77 percent alcohol as an inactive ingredient. The requirement consists of two line items totaling five 16-ounce bottles. This is a fixed-price acquisition with a 20-day delivery requirement, and the items are to be delivered FOB Destination to specified locations, including sites in Germany and California. The contract includes stringent technical, safety, and quality requirements. The item is classified as a Type I (Code Q) item with a 36-month shelf life, requiring a minimum of 31 months of remaining shelf life at the time of receipt. Because the tincture is flammable and contains alcohol, it is classified as hazardous material; therefore, the contractor must provide a current Material Safety Data Sheet (MSDS) with each shipment and ensure packaging complies with 49 CFR and ICAO or IMDG regulations. Marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Additionally, the procurement is subject to domestic preference regulations, including the Buy American Act and the Berry Amendment, and requires compliance with cybersecurity standards for safeguarding covered defense information. Quotations must be submitted via the DIBBS system by the October 5, 2026, deadline.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
ALBENDAZOLE TABLETS
Solicitation # SPE2DP-26-T-5312
This solicitation, issued by the DLA Troop Support Medical Supply Chain on September 29, 2026, is a Request for Quotations for Albendazole Tablets, USP. The procurement consists of two separate line items: one for 2 bottles and another for 56 bottles, with each bottle containing two 200 mg tablets. The items are FDA-regulated and must meet a Type I (Code M) shelf-life requirement of 24 months, which is non-extendable. Storage requirements mandate a controlled room temperature between 20° to 25°C (68° to 77°F). This is not a small business set-aside, and quotes must be submitted via the DIBBS system by the deadline of October 5, 2026. The contract specifies destination-based inspection and acceptance, with delivery required within five days. Shipping destinations include the USS Gettysburg CG 64 at FPO AA 34091 and USALRCTR Bavaria in Germany. Packaging must be commercial and suitable for protecting contents from damage, with specific protocols for hazardous versus non-hazardous materials. Marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The contract incorporates various federal and defense regulations, including requirements for safeguarding covered defense information, cybersecurity reporting, and compliance with the Buy American Act. Additionally, the government prohibits the use of additive manufacturing for any supplied parts or supplies unless specifically authorized.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
IMIDACLOPRID AND PERME
Solicitation # SPE2DP-26-T-5278
Solicitation SPE2DP-26-T-5278 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Advantage II flea and lice treatment for large dogs over 55 pounds. The required product is a fragrance-free, waterproof solution containing 9.10 percent Imidacloprid and 0.46 percent Pyriproxyfen, delivered in packages of four 2.5ml tubes. This material has no shelf-life requirement. The government is seeking one package with a required delivery date of September 29, 2026, to be delivered FOB Destination to the 0240 QM Support Company at Smith Barracks in Baumholder, Germany, within 20 days after receipt of order. Compliance with strict packaging and marking standards is mandatory, specifically MIL-STD-2073-1E, MIL-STD-129, and Medical Marking Standard No. 1. Because the solution is classified as a hazardous material, suppliers must submit Safety Data Sheets and Hazardous Communication Standard labels for review and approval prior to award in accordance with 29 C.F.R. 1910.1200 and Federal Standard No. 313-E. Quotes must be submitted via the DIBBS system by October 5, 2026. The contract incorporates various federal regulations, including the Buy American Act, Berry Amendment, and requirements for the safeguarding of covered defense information. Invoicing and payment shall be processed electronically through the Wide Area WorkFlow system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS